Erratum: Early results of sarcomeric gene screening from the Egyptian national BA-HCM program (Journal of Cardiovascular Translational Research DOI:10.1007/s12265-012-9425-0);Early results of sarcomeric gene screening from the egyptian national BA-HCM program

Journal of Cardiovascular Translational Research

Volumn 6, Issue 1, 2013, Pages 65-80

  Kassem, Heba Sh ^a,b,g   Azer, Remon S ^a   Ayad, Maha S ^c   Moharem Elgamal, Sarah ^a,d   Magdy, Gehan ^a,b   Elguindy, Ahmed ^a   Cecchi, Franco ^e   Olivotto, Iacopo ^e   Yacoub, Magdi H ^a,f  

^a Magdi Yacoub Heart Foundation   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c UNIVERSITY OF SHARJAH   (United Arab Emirates)

^d NATIONAL HEART INSTITUTE   (Egypt)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g BIBLIOTHECA ALEXANDRINA   (Egypt)

Author keywords

Egypt; HCM genetics; Sarcomeric genotyping

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN BETA; THREONINE; TROPONIN T;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CPG ISLAND; EGYPTIAN; ETHNICITY; FAMILY HISTORY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HEALTH PROGRAM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MYBPC3 GENE; MYH7 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SARCOMERE; SINGLE NUCLEOTIDE POLYMORPHISM; TNNT2 GENE;

EID: 84872612727     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9478-8     Document Type: Erratum

References (52)

1. Cecchi, F; Yacoub, M. H; & Olivotto, I. (2005). Hypertrophic cardiomyopathy in the community: why we should care. Nature Clinical Practice. Cardiovascular Medicine, 2(7), 324-325. (Pubitemid 41670312)
2. Maron, B. J; Gardin, J. M; Flack, J. M; Gidding, S. S; Kurosaki, T. T; & Bild, D. E. (1995). Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation, 92(4), 785-789.
3. Maron, B. J. (2004). Hypertrophic cardiomyopathy: an important global disease. American Journal of Medicine, 116(1), 63-65. (Pubitemid 38050032)
4. Maron, B. J; & Ho, C. Y. (2009). Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members. JACC. Cardiovascular Imaging, 2(1), 65-68.
5. http://www.indexmundi.com/egypt/population.html (accessed July17, 2012).
6. Van Driest, S. L; Ommen, S. R; Tajik, A. J; Gersh, B. J; & Ackerman, M. J. (2005). Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clinic Proceedings, 80(6), 739-744. (Pubitemid 40770360)
7. Konno, T; Chang, S; Seidman, J. G; & Seidman, C. E. (2010). Genetics of hypertrophic cardiomyopathy. Current Opinion in Cardiology, 25(3), 205-209.
8. Watkins, H; Ashrafian, H; & Redwood, C. (2011). Inherited cardiomyopathy. NEJM, 364, 1643-1656.
9. Funada, A; Masuta, E; Fujino, N; Hayashi, K; Ino, H; Kita, Y; Ikeda, H; Fujii, T; Nakanuma, Y; & Yamagishi, M. (2010). Heterogeneity of clinical manifestation of hypertrophic cardiomyopathy caused by deletion of lysine 183 in cardiac troponin I gene. International Heart Journal, 51(3), 214-217.
10. Daw, E. W; Chen, S. N; Czernuszewicz, G; Lombardi, R; Lu, Y; Ma, J; Roberts, R; Shete, S; & Marian, A. J. (2007). Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. Human Molecular Genetics, 16, 2463-2471. (Pubitemid 47500632)
11. Kalozoumi, G; Tzimas, C; Sanoudou, D. (2012). The expanding role of epigenetics. Global Cardiology Science and Practice, 7: http://dx.doi.org/ 10.5339/gcsp.2012.7
12. Richard, P; Charron, P; Carrier, L; Ledeuil, C; Cheav, T; Pichereau, C; et al. (2003). Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation, 107(17), 2227-2232. (Pubitemid 36547217)
13. Van Driest, S. L; Jaeger, M. A; Ommen, S. R; Will, M. L; Gersh, B. J; Tajik, A. J; et al. (2004). Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 44(3), 602-610. (Pubitemid 39078187)
14. Girolami, F; Olivotto, I; Passerini, I; Zachara, E; Nistri, S; Re, F; et al. (2006). A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. Journal of Cardiovascular Medicine, 7(8), 601-607. (Pubitemid 44350495)
15. Morner, S; Richard, P; Kazzam, E; Hellman, U; Hainque, B; Schwartz, K; et al. (2003). Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. Journal of Molecular and Cellular Cardiology, 35(7), 841-849. (Pubitemid 36775341)
16. Marian, A. J; Salek, L; & Lutucuta, S. (2001). Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Minerva Medica, 92(6), 435-451. (Pubitemid 34184275)
17. Fokstuen, S; Lyle, R; Munoz, A; Gehrig, C; Lerch, R; Perrot, A; et al. (2008). A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy. Human Mutation, 29(6), 879-885. (Pubitemid 351794139)
18. Niimura, H; Bachinski, L. L; Sangwatanaroj, S; Watkins, H; Chudley, A. E; McKenna, W; et al. (1998). Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. The New England Journal of Medicine, 338(18), 1248-1257. (Pubitemid 28216578)
19. Olivotto, I; Girolami, F; Ackerman, M. J; Nistri, S; Bos, J. M; Zachara, E; et al. (2008). Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clinic Proceedings, 83(6), 630-638. (Pubitemid 351810562)
20. Erdmann, J; Daehmlow, S; Wischke, S; Senyuva, M; Werner, U; Raible, J; et al. (2003). Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clinical Genetics, 64(4), 339-349. (Pubitemid 37236134)
21. Frisso, G; Limongelli, G; Pacileo, G; Del Giudice, A; Forgione, L; Calabro, P; et al. (2009). A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy. Clinical Genetics, 76(1), 91-101.
22. Garcia-Castro, M; Reguero, J. R; Alvarez, V; Batalla, A; Soto, M. I; Albaladejo, V; et al. (2005). Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect. International Journal of Cardiology, 102(3), 501-507. (Pubitemid 40956911)
23. Alders, M; Jongbloed, R; Deelen, W; van den Wijngaard, A; Doevendans, P; Ten Cate, F; et al. (2003). The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. European Heart Journal, 24(20), 1848-1853. (Pubitemid 37280251)
24. Millat, G; Bouvagnet, P; Chevalier, P; Dauphin, C; Jouk, P. S; Da Costa, A; et al. (2010). Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. European Journal of Medical Genetics, 53(5), 261-267.
25. Rodriguez-Garcia, M. I; Monserrat, L; Ortiz, M; Fernandez, X; Cazon, L; Nunez, L; et al. (2010). Screening mutations in myosin binding protein C3 gene in a cohort of patients with hypertrophic cardiomyopathy. BMC Medical Genetics, 11, 67.
26. Rosenzweig, A; Watkins, H; Hwang, D. S; Miri, M; McKenna, W; Traill, T. A; et al. (1991). Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. The New England Journal of Medicine, 325(25), 1753-1760.
27. Watkins, H; Rosenzweig, A; Hwang, D. S; Levi, T; McKenna, W; Seidman, C. E; et al. (1992). Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. The New England Journal of Medicine, 326(17), 1108-1114.
28. Song, L; Zou, Y; Wang, J; Wang, Z; Zhen, Y; Lou, K; et al. (2005). Mutations profile in Chinese patients with hypertrophic cardiomyopathy. Clinica Chimica Acta, 351(1-2), 209-216. (Pubitemid 39563577)
29. Consevage, M. W; Salada, G. C; Baylen, B. G; Ladda, R. L; & Rogan, P. K. (1994). A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. Human Molecular Genetics, 3(6), 1025-1026. (Pubitemid 24189987)
30. Kato, M; Takazawa, K; Kimura, A; Ruegg, J. C; Amano, K; Wang, Y; et al. (1995). Altered actin binding with myosin mutation in hypertrophic cardiomyopathy and sudden death. Lancet, 345(8959), 1247.
31. Moolman-Smook, J. C; Brink, P. A; & Corfield, V. A. (1995). Identification of a novel Ala797Thr mutation in exon 21 of the beta-myosin heavy chain gene in hypertrophic cardiomyopathy. Human Mutation, 6(2), 197-198.
32. Yu, B; Sawyer, N. A; Caramins, M; Yuan, Z. G; Saunderson, R. B; Pamphlett, R; et al. (2005). Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease. Journal of Clinical Pathology, 58(5), 479-485. (Pubitemid 40646866)
33. Roncarati, R; Latronico, M. V; Musumeci, B; Aurino, S; Torella, A; Bang, M. L; et al. (2011). Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy. Journal of Cellular Physiology, 226(11), 2894-2900.
34. Moolman, J. C; Corfield, V. A; Posen, B; Ngumbela, K; Seidman, C; Brink, P. A; & Watkins, H. (1997). Sudden death due to troponin T mutations. Journal of the American College of Cardiology, 29(3), 549-555. (Pubitemid 27116096)
35. Watkins, H; McKenna, W. J; Thierfelder, L; Suk, H. J; Anan, R; O'Donoghue, A; Spirito, P; Matsumori, A; Moravec, C. S; Seidman, J. G; et al. (1995). Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. The New England Journal of Medicine, 332(16), 1058-1064.
36. Exome variant Server v.0.0.13, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA (URL: http://evs.gs.washington.edu/EVS/).
37. Curila, K; Benesova, L; Penicka, M; Minarik, M; Zemanek, D; Veselka, J; Widimsky, P; & Gregor, P. (2012). Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy. Acta Cardiologica, 67(1), 23-29.
38. Moolman-Smook, J. C; De Lange, W. J; Bruwer, E. C. D; Brink, P. A; & Corfield, V. A. (1999). The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. American Journal of Human Genetics, 65, 1308-1320. (Pubitemid 30460381)
39. Yang, J; Zheng, D; Dong, N; Yang, X; Song, J; Jiang, T; Cheng, X; Li, H; Zhou, B; Zhao, C; & Jiang, W. (2006). Mutation of Arg723Gly in β-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy. Chinese Medical Journal, 119, 1785-1789. (Pubitemid 44768607)
40. Christiaans, I; Nannenberg, E. A; Dooijes, D; Jongbloed, R. J. E; Michels, M; Postema, P. G; Majoor-Krakauer, D; Van den Wijngaard, A; Mannens, M. M. A. M; Van Tintelen, J. P; Van Langen, I. M; & Wilde, A. A. M. (2010). Founder mutations in hypertrophic cardiomyopathy in the Netherlands. Netherlands Heart Journal, 18, 248-254.
41. Bell, J; Bodmer, D; Sistermans, E; Ramsden, S. C. (2007). Practice guidelines for the interpretation and reporting of unclassified variants (UVs) in clinical molecular genetics. CMGS/VKGL.
42. Krawczak, M; Ball, E. V; & Cooper, D. N. (1998). Neighboring- nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. American Journal of Human Genetics, 63(2), 474-488. (Pubitemid 30418629)
43. Cooper, D. N; Krawczak, M. (1999). Single base pair substitutions. In Human gene mutations. Oxford: BIOS Scientific. pp 109-162.
44. Walsh, C. P; & Xu, G. L. (2006). Cytosine methylation and DNA repair. Current Topics in Microbiology and Immunology, 301, 283-315. (Pubitemid 43022677)
45. Antonarakis, S. E; Krawczak, M; & Cooper, D. N. (2001). The nature and mechanisms of human gene mutation. In C. R. Scriver & W. S. Sly (Eds.), The metabolic and molecular basis of inherited disease (pp. 343-377). New York: McGraw-Hill.
46. Meurs, K. M; & Mealey, K. L. (2008). Evaluation of the flanking nucleotide sequences of sarcomeric hypertrophic cardiomyopathy substitution mutations. Mutation Research, 642(1-2), 86-89.
47. Ertz-Berger, B. R; He, H; Dowell, C; Factor, S. M; Haim, T. E; Nunez, S; Schwartz, S. D; Ingwall, J. S; & Tardiff, J. C. (2005). Changes in the chemical and dynamic properties of cardiac troponin t cause discrete cardiomyopathies in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 102, 18219-18224. (Pubitemid 41798528)
48. Forissier, J. F; Carrier, L; Farza, H; Bonne, G; Bercovici, J; Richard, P; Hainque, B; Townsend, P. J; Yacoub, M. H; Faure, S; et al. (1996). Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation, 94, 3069-3073. (Pubitemid 26427467)
49. Moolman-Smook, J. C; De Lange, W. J; Bruwer, E. C. D; Brink, P. A; & Corfield, V. A. (1999). The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. American Journal of Human Genetics, 65, 1308-1320. (Pubitemid 30460381)
50. Alders, M; Jongbloed, R; Deelen, W; van den Wijngaard, A; Doevendans, P; Ten Cate, F; Regitz-Zagrosek, V; Vosberg, H. P; van Langen, I; Wilde, A; Dooijes, D; & Mannens, M. (2003). The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. European Heart Journal, 24(20), 1848-1853. (Pubitemid 37280251)
51. Kassem, H. S; Girolami, F; Sanoudou, D. (2012). Molecular genetics made simple. Global Cardiology Science & Practice, 2, http://dx.doi.org/ 10.5339/gcsp.2012.6
52. Olivotto, I; Kassem H Sh, Girolami F. (2011). Genetic testing for hyptertrophic cardiomyopathy. From exploration to exploitation. Cardiogenetics [eISSN 2035-8148], Vol 1, e3.